tiprankstipranks
Trending News
More News >
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN

Compare BioMarin Pharmaceutical (BMRN) vs. Competitors

Compare
2,376 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
BioMarin Pharmaceutical
$56.08
$10.77B
21.01
-12.11%
14 Buy
5 Hold
0 Sell
Moderate Buy
Jazz Pharmaceuticals
$170.81
$10.38B
-28.14
38.92%
12 Buy
1 Hold
0 Sell
Strong Buy
PTC Therapeutics
$77.29
$6.21B
9.03
84.86%
8 Buy
5 Hold
1 Sell
Moderate Buy
Ultragenyx Pharmaceutical
$24.07
$2.32B
-4.05
-39.86%
17 Buy
1 Hold
0 Sell
Strong Buy
Summit Therapeutics
$17.65
$13.14B
-14.21
6.01%
8 Buy
3 Hold
1 Sell
Moderate Buy
Immunovant
$27.35
$5.51B
-9.67
19.54%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BMRN
BioMarin Pharmaceutical
56.08
-5.17
-8.44%
JAZZ
Jazz Pharmaceuticals
170.81
48.19
39.30%
PTCT
PTC Therapeutics
77.29
34.21
79.41%
RARE
Ultragenyx Pharmaceutical
24.07
-16.78
-41.08%
SMMT
Summit Therapeutics
17.65
-0.54
-2.97%
IMVT
Immunovant
27.35
3.55
14.92%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts